Pfizer Inc (PFE)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
Our last 30 days of resolved calls came true 43% of the time.See the track record →
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
- 52-week positionPressing 52-week highs+30
- QualityRevenue shrinking (-0% y/y)-4
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →
🤖 The dominant catalyst is macro, as higher interest rates and dividend-yield concerns are driving the narrative around PFE rather than company-specific news. Continuation likelihood over the next few weeks is moderate (~55%), since rate sensitivity and dividend skepticism tend to persist as themes until the next earnings or guidance update. Informational only — not financial advice.
- What Sent Eli Lilly Stock Higher Over The Past Year?Yahoo · 2026-10-23
- Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?Yahoo · 2026-10-23
- U.S. Treasury Wants to Rein In Deals for Chinese Biotech and AIYahoo · 2026-10-23
- How Much Downside Is Left In Moderna Stock?Yahoo · 2026-10-23
- What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and PfizerYahoo · 2026-10-23
Any AI summary is an interpretation of public news, not advice or a price target.